相似文献
1
Re: Regulatory Toxicology and Pharmacology.
Int J Occup Environ Health. 2003 Oct-Dec;9(4):390; author reply 390-1.
2
Re: Regulatory Toxicology and Pharmacology.
Int J Occup Environ Health. 2003 Oct-Dec;9(4):386-9; author reply 389-90. doi: 10.1179/oeh.2003.9.4.386.
3
Competing interests.
Nat Biotechnol. 2003 Oct;21(10):1131. doi: 10.1038/nbt1003-1131a.
4
Disclosure.
J Am Coll Radiol. 2019 Mar;16(3):269-270. doi: 10.1016/j.jacr.2019.01.029.
5
Authors, industry, and review articles.
J Am Coll Cardiol. 2004 Mar 17;43(6):1130-1. doi: 10.1016/j.jacc.2004.02.007.
6
Re: Regulatory Toxicology and Pharmacology, volume 52, issue 1, supplement 1.
Regul Toxicol Pharmacol. 2009 Jul;54(2):210; discussion 211-2. doi: 10.1016/j.yrtph.2009.03.009. Epub 2009 Apr 2.
7
How Japanese medical journals manage conflicts of interest.
Chest. 2015 Feb;147(2):e60. doi: 10.1378/chest.14-2396.
8
Medical journals and conflicts of interest.
J Law Med Ethics. 2012 Fall;40(3):488-99. doi: 10.1111/j.1748-720X.2012.00681.x.
9
Nothing to see here.
Nat Biotechnol. 2008 May;26(5):476. doi: 10.1038/nbt0508-476.
10
Ghostbusters should only bust ghosts.
Nat Biotechnol. 2008 Oct;26(10):1067-8. doi: 10.1038/nbt1008-1067.
Zotero 插件